Press Releases on November 10, 2016 - EIN Presswire - Press Release Distribution Service

Published on November 10, 2016 - 12:00 GMT

Neos Therapeutics Reports Third Quarter 2016 Financial Results

DALLAS/FORT WORTH, Texas, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products for the treatment of attention- …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry

Published on November 10, 2016 - 12:00 GMT

Kamada Reports Financial Results for the Third Quarter and Nine Months of 2016

Total Revenues for Third Quarter 2016 Grew 21% to $19.4 Million vs. Third Quarter 2015 Proprietary Products Revenue Grew 57% to $15.0 Million in Third Quarter 2016 vs. Third Quarter 2015 Company Reiterates 2016 Revenue Guidance of $75 to $80 Million and …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry

Published on November 10, 2016 - 12:00 GMT

Boxwood Launches Environmental Giving Campaign

Stamford, Conn., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Boxwood Means, LLC, a leading provider of property valuations and data analytics in the U.S. small-cap commercial real estate market, is pleased to announce that it is pledging a percentage of its …

Distribution channels: Real Estate & Property Management

Published on November 10, 2016 - 12:00 GMT

Aptose To Release Third Quarter Ended September 30, 2016 Financial Results and Hold Conference Call on November 15, 2016

SAN DIEGO and TORONTO, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, will release …

Distribution channels: Conferences & Trade Fairs, Technology

Published on November 10, 2016 - 12:00 GMT

Axsome Therapeutics Enters into $20 Million Term Loan Agreement with Silicon Valley Bank

NEW YORK, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, announced today that it has entered …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry

Published on November 10, 2016 - 12:00 GMT

VBL Therapeutics Announces Third Quarter 2016 Financial Results and Provides Business Update

TEL AVIV, Israel, Nov. 10, 2016 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), today reported financial results and provided a business update for the third quarter and nine month period ended September 30, 2016. “We continue to focus our resources on …

Distribution channels: Banking, Finance & Investment Industry, Technology

Published on November 10, 2016 - 12:00 GMT

Recro Pharma Reports Third Quarter 2016 Financial Results

Announced Positive Phase III Results from Pivotal Trial of IV Meloxicam Following Bunionectomy Surgery Pivotal Phase III Trial of IV Meloxicam Following Mini Abdominoplasty Surgery Ongoing; Top-line Data Expected by Year End MALVERN, Pa., Nov. 10, 2016 ( …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry

Published on November 10, 2016 - 12:00 GMT

NeuroDerm Announces Third Quarter 2016 Financial Results

REHOVOT, Israel, Nov. 10, 2016 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced financial results for the third quarter ended September 30 …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry

Published on November 10, 2016 - 12:00 GMT

ZIOPHARM to Present at the Jefferies 2016 London Healthcare Conference

BOSTON, Nov. 10, 2016 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies 2016 London Healthcare Conference on Thursday, November 17, 2016 at 4: …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on November 10, 2016 - 12:00 GMT

BlueLinx Announces Third-Quarter Results

– Net income of $15.0 million; highest quarter net income since 2004 – – Diluted earnings per share of $1.68 – – Debt principal reduction of $87.2 million from Q3 2015 – ATLANTA, Nov. 10, 2016 (GLOBE NEWSWIRE) -- BlueLinx Holdings Inc. (NYSE:BXC), a …

Distribution channels: Banking, Finance & Investment Industry, Technology

Published on November 10, 2016 - 12:00 GMT

Pluristem’s $30 Million Equity Funding Approved by Innovative Medical Management Co.’s Shareholders

Term sheet for investment at $1.77 per share is now binding Innovative Medical is a publicly listed Chinese company active in the healthcare industry, and is an affiliate of ZSVC, one of the largest technology-focused VC firms in China HAIFA, Israel, Nov. …

Distribution channels: Technology

Published on November 10, 2016 - 12:00 GMT

Great Basin Scientific to Demonstrate its Diagnostics Platform at AMP 2016

SALT LAKE CITY, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, will demonstrate its molecular diagnostics platform at the Association for Molecular Pathology (AMP) 2016 Annual Meeting in …

Distribution channels: Conferences & Trade Fairs, Technology

Published on November 10, 2016 - 12:00 GMT

Merus to Present at the Jefferies London Healthcare Conference

UTRECHT, The Netherlands, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton Logtenberg, CEO, will present at the Jefferies …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on November 10, 2016 - 12:00 GMT

Anthera Announces that the Blisibimod CHABLIS-SC1 Phase 3 Study Did Not Achieve the Primary Endpoint in Patients with Active ...

Assessing next steps for blisibimod for the treatment of Systemic Lupus Erythematosus Continuing to explore blisibimod as treatment for IgA nephropathy – Phase 2 data in December SollpuraTM SOLUTION phase 3 study in exocrine pancreatic insufficiency on …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on November 10, 2016 - 12:00 GMT

Kratos Digital IF Demodulator Selected For U.S. Army Telemetry Modernization Program

SAN DIEGO, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its RT Logic subsidiary was awarded a contract for its Telemetrix 400 Range …

Distribution channels: Aviation & Aerospace Industry, Business & Economy

Published on November 10, 2016 - 12:00 GMT

Cancer Genetics, Inc. Announces Strong Third Quarter with 68% Year Over Year Revenue Growth and Highlights Path to Future ...

Company reports third quarter revenues of $6.8 Million, an increase of 68% over the third quarter of 2015 The revenue growth rate was 58% for the first 9 months of 2016 as compared to 2015 Company continues to decrease operating expenses both in sequential …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry

Published on November 10, 2016 - 12:00 GMT

Tonix Pharmaceuticals to Present New Clinical Results from Retrospective Analysis of Phase 2 AtEase Study in Military-Related PTSD

NEW YORK, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), which is developing a next-generation treatment for posttraumatic stress disorder (PTSD), will announce new results today from a retrospective analysis …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on November 10, 2016 - 12:00 GMT

Proteostasis Therapeutics Reports Third Quarter 2016 Financial Results

CAMBRIDGE, Mass., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing such as cystic fibrosis, today …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry

Published on November 10, 2016 - 11:58 GMT

Ag Growth Announces Third Quarter 2016 Results and Dividends; Announcement of Strategic Acquisition

WINNIPEG, MANITOBA--(Marketwired - Nov 10, 2016) - Ag Growth International Inc. (TSX:AFN) ("AGI" or the "Company") today announced its financial results for the three and nine-month periods ended September 30, 2016, and declared …

Distribution channels: Agriculture, Farming & Forestry Industry, Consumer Goods

Published on November 10, 2016 - 11:58 GMT

Stantec reports third quarter 2016 results and appointment of a new director

EDMONTON, ALBERTA and NEW YORK, NEW YORK--(Marketwired - Nov 10, 2016) - (TSX:STN)(NYSE:STN) Stantec reported a strong 67.5% increase in gross revenue when comparing the third quarter of 2016 to the same period last year. The increase was mainly due to …

Distribution channels: Real Estate & Property Management